Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer, has executed a purchase and sale agreement to acquire 10.7 acres of land adjacent to their facility in Spokane, WA.   The company specializes in the manufacture (fill and finish) of injectable drugs, including vaccines and biological therapeutics. The campus expansion will support Selkirk’s growth and add critically needed capacity for the manufacture of commercial and clinical trial drugs.   “Spokane is a special place to ...